2nd International Symposium 3-D radiation. Treatment planning and conformal therapy. 11-13 April 1996, St Louis, MO, USA;Radiotherapie de conformation tridimensionnelle. Compte rendu du '2nd International Symposium 3-D radiation treatment planning and conformal therapy'. 11-13 Avril 1996 a Saint-Louis, Missouri, Etats-Unis

Bulletin du Cancer/Radiotherapie

Volumn 83, Issue 3, 1996, Pages 187-195

  Touboul, E ^a   Foulquier, J N ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL; TREATMENT PLANNING; ADENOCARCINOMA; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; IMAGE PROCESSING; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; PATHOLOGY; PROSTATE TUMOR; QUALITY OF LIFE; RADIATION DOSE; RADIATION RESPONSE; RADIOMETRY; TREATMENT OUTCOME; UNITED STATES;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TREATMENT OUTCOME; UNITED STATES;

EID: 0029811572     PISSN: 09244212     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-4212(96)81757-9     Document Type: Conference Paper

References (16)

1. 1 Bolla M, Berland E, Dusserre A et al. Radiothérapie conformative tridimensionnelle. Définition et procédure. Bull Cancer/Radiother 1995:82:238-41
2. 2 Busse W. Einstellung und Dosibestimmung bei der Pendelbestrahlung der parametriam. Strahlentherapie 1956;101:400-4
3. 3 Carrie C, Ginestet C, Bey P et al. Fédération nationale des centres de lutte contre le cancer (FNCLCC). Radiothérapie conformationnelle. Bull Cancer 1995;82:325-30
4. 4 Coquard R, Ginestet C, Sentenac I, Carrie C, Gérard JP. La radiothérapie de conformation en 1995 : acquis technologique et perspectives cliniques. Bull Cancer/Radiother 1995;82:40-50
5. 5 Frass BA. The development of conformal radiation therapy. Med Phys 1995;22:1911-21
6. 6 Friedman M, Hine GJ, Dresner J. Principles of supervoltage (2 million volts) rotation therapy. Radiology 1955;64:1-16
7. 7 Martinez A, Gonzalez J, Stromberg J et al. Conformal prostate brachytherapy: initial experience of a phase I/II dose escalating trial. Int J Radiat Oncol Biol Phys 1995;33:1019-27
8. 8 Partin AW, Yoo J, Carter HB et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathologic stage in men with localized prostate cancer. J Urol 1993;150:110-4
9. 9 Proimos BS. Synchronous field shaping in rotational megavolt therapy. Radiology 1960:74:753-7
10. 10 Roach M. Equation for predicting the pathologic stage of men with localized prostate cancer using the preoperative prostate specific antigen (PSA) and Gleason score. J Urol 1993; 150:1923-4
11. 11 Stock RG, Stone NN, Iannuzi C, Linger P. Seminal vesicle biopsy, and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer. Int J Radiat Oncol Biol Phys 1995;33:815-21
12. 12 Takahashi S, Kitabatake T, Morita K, Okajima S, Iida H. Methoden zur besseren Anpassung der Dosiverteilung an tiefliegende Krankenheitsherde bei der bewegungsbestrahlung. Strahlentherapie 1961;115:478-88
13. 13 Three-Dimensional Photon Treatment planning. Report of the Collaborative Working Group on the evaluation of treatment planning for external photon beam radiotherapy. Smith AR, Purdy JA, eds. Int J Radiat Oncol Biol Phys 1991;21:1-266
14. 14 Touboul E, Lefkopoulos D. Radiothérapie de conformation tridimensionnelle. Compte rendu du 3D Radiation Treatment Planning and Conformal Therapy. An International Symposium. 21-23 avril 1993 à Saint-Louis, Missouri, États-Unis. Bull Cancer/Radiother 1994:81:7-21
15. 15 Worskshop on the implementation of three dimensional conformai radiotherapy. Smith AR, Ling CC, eds. Int J Radiat Oncol Biol Phys 1995:33:977-1348
16. 16 Zelefsky MJ, Leibel SA, Burman CM et al. Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformai radiation therapy. Int J Radiat Oncol Biol Phys 1994;29:755-61